Medistim ASA (FRA:MD1)
Germany flag Germany · Delayed Price · Currency is EUR
17.55
+0.25 (1.45%)
Last updated: Jun 5, 2025

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of EUR 327.94 million. The enterprise value is 314.29 million.

Market Cap 327.94M
Enterprise Value 314.29M

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date May 9, 2025
Ex-Dividend Date May 9, 2025

Share Statistics

Current Share Class 18.25M
Shares Outstanding n/a
Shares Change (YoY) +0.06%
Shares Change (QoQ) -0.27%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 12.61M

Valuation Ratios

The trailing PE ratio is 30.35 and the forward PE ratio is 28.87.

PE Ratio 30.35
Forward PE 28.87
PS Ratio 6.17
PB Ratio 7.99
P/TBV Ratio 9.26
P/FCF Ratio 27.88
P/OCF Ratio 26.67
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.99, with an EV/FCF ratio of 26.72.

EV / Earnings 29.08
EV / Sales 6.00
EV / EBITDA 19.99
EV / EBIT 22.89
EV / FCF 26.72

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.

Current Ratio 3.91
Quick Ratio 2.52
Debt / Equity 0.06
Debt / EBITDA 0.14
Debt / FCF 0.20
Interest Coverage 194.08

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE) 27.42%
Return on Assets (ROA) 17.26%
Return on Invested Capital (ROIC) 21.22%
Return on Capital Employed (ROCE) 31.82%
Revenue Per Employee 344,895
Profits Per Employee 70,174
Employee Count 154
Asset Turnover 1.05
Inventory Turnover 0.73

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.33% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +8.33%
50-Day Moving Average 15.45
200-Day Moving Average 14.06
Relative Strength Index (RSI) 59.33
Average Volume (20 Days) 104

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of EUR 53.11 million and earned 10.81 million in profits. Earnings per share was 0.59.

Revenue 53.11M
Gross Profit 42.62M
Operating Income 13.91M
Pretax Income 14.10M
Net Income 10.81M
EBITDA 15.16M
EBIT 13.91M
Earnings Per Share (EPS) 0.59
Full Income Statement

Balance Sheet

The company has 16.13 million in cash and 2.30 million in debt, giving a net cash position of 13.83 million.

Cash & Cash Equivalents 16.13M
Total Debt 2.30M
Net Cash 13.83M
Net Cash Per Share n/a
Equity (Book Value) 41.02M
Book Value Per Share 2.25
Working Capital 30.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.30 million and capital expenditures -533,668, giving a free cash flow of 11.76 million.

Operating Cash Flow 12.30M
Capital Expenditures -533,668
Free Cash Flow 11.76M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.

Gross Margin 80.25%
Operating Margin 26.19%
Pretax Margin 26.54%
Profit Margin 20.35%
EBITDA Margin 28.55%
EBIT Margin 26.19%
FCF Margin 22.15%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.92%.

Dividend Per Share 0.51
Dividend Yield 2.92%
Dividend Growth (YoY) 33.88%
Years of Dividend Growth n/a
Payout Ratio 67.07%
Buyback Yield -0.06%
Shareholder Yield 2.86%
Earnings Yield 3.30%
FCF Yield 3.59%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a